261 related articles for article (PubMed ID: 19043842)
1. Trial will evaluate a once-daily dose of raltegravir.
AIDS Patient Care STDS; 2008 Nov; 22(11):918-9. PubMed ID: 19043842
[No Abstract] [Full Text] [Related]
2. Raltegravir phase III study data released.
AIDS Patient Care STDS; 2008 Nov; 22(11):917. PubMed ID: 19043838
[No Abstract] [Full Text] [Related]
3. A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate.
De Clercq E
Expert Opin Pharmacother; 2009 Dec; 10(17):2935-7. PubMed ID: 19929712
[TBL] [Abstract][Full Text] [Related]
4. Initial results reported on raltegravir once-daily dosing.
AIDS Patient Care STDS; 2011 Feb; 25(2):123. PubMed ID: 21370546
[No Abstract] [Full Text] [Related]
5. HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.
Cohen J
Science; 2010 Dec; 330(6009):1298-9. PubMed ID: 21127220
[No Abstract] [Full Text] [Related]
6. Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial.
Byakwaga H; Kelly M; Purcell DF; French MA; Amin J; Lewin SR; Haskelberg H; Kelleher AD; Garsia R; Boyd MA; Cooper DA; Emery S;
J Infect Dis; 2011 Nov; 204(10):1532-40. PubMed ID: 21930607
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV agents. Integrase inhibitor raltegravir makes its mark.
TreatmentUpdate; 2007 Feb; 19(2):8-9. PubMed ID: 17447316
[No Abstract] [Full Text] [Related]
8. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
[TBL] [Abstract][Full Text] [Related]
9. Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium.
Nguyen BY; Isaacs RD; Teppler H; Leavitt RY; Sklar P; Iwamoto M; Wenning LA; Miller MD; Chen J; Kemp R; Xu W; Fromtling RA; Vacca JP; Young SD; Rowley M; Lower MW; Gottesdiener KM; Hazuda DJ
Ann N Y Acad Sci; 2011 Mar; 1222():83-9. PubMed ID: 21434946
[TBL] [Abstract][Full Text] [Related]
10. [Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens].
Kravchenko AV
Ter Arkh; 2010; 82(11):27-32. PubMed ID: 21381345
[TBL] [Abstract][Full Text] [Related]
11. Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient.
Wandeler G; Furrer H; Rauch A
AIDS; 2011 Nov; 25(18):2306-8. PubMed ID: 22067200
[No Abstract] [Full Text] [Related]
12. First-line raltegravir. No evidence of comparative effectiveness.
Prescrire Int; 2010 Nov; 19(110):248-50. PubMed ID: 21284354
[TBL] [Abstract][Full Text] [Related]
13. Raltegravir: is a 400 mg once-daily dose enough?
Lanzafame M; Hill A; Lattuada E; Calcagno A; Bonora S
J Antimicrob Chemother; 2010 Mar; 65(3):595-7. PubMed ID: 20071368
[No Abstract] [Full Text] [Related]
14. [Integrase inhibition].
Bogner JR
MMW Fortschr Med; 2009 Apr; 151(18):68-71. PubMed ID: 19769082
[No Abstract] [Full Text] [Related]
15. [New fixed combination for HIV therapy].
Krankenpfl J; 2005; 43(4-6):95. PubMed ID: 16171046
[No Abstract] [Full Text] [Related]
16. [Raltegravir as first integrase inhibitor in an HIV-infection].
Papendorp SG; Brinkman K
Ned Tijdschr Geneeskd; 2009 Jan; 153(5):166-7. PubMed ID: 19256240
[No Abstract] [Full Text] [Related]
17. Two-once-daily fixed-dose NRTI combinations for HIV.
Med Lett Drugs Ther; 2005 Feb; 47(1203):19-20. PubMed ID: 15767973
[TBL] [Abstract][Full Text] [Related]
18. [Simply convincing. New fixed combination for HIV therapy].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
[No Abstract] [Full Text] [Related]
19. 96-week CASTLE data show similar efficacy results.
AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
[No Abstract] [Full Text] [Related]
20. Raltegravir: the first HIV integrase inhibitor.
Cocohoba J; Dong BJ
Clin Ther; 2008 Oct; 30(10):1747-65. PubMed ID: 19014832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]